Literature DB >> 19183980

Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion.

John Knight1, Linda H Easter, Rebecca Neiberg, Dean G Assimos, Ross P Holmes.   

Abstract

High animal protein intake is a risk factor for calcium oxalate stone disease. The effect of dietary protein on the urinary excretion of calcium, acid and citrate is well established. However, its effect on oxalate excretion is unclear, due in part to an inadequate control of dietary oxalate intake in previous studies. This relationship warrants clarification due to the proposed important role of the metabolism of amino acids in endogenous oxalate synthesis. In this study, 11 normal subjects consumed controlled oxalate diets containing 0.6, 1.2 and 1.8 g protein/kg body weight/day. The analysis of 24 h urine collections confirmed that as protein intake increased, urinary calcium and glycolate increased and urinary pH and citrate decreased. The increased glycolate excretion was due in part to an increased hydroxyproline, but not glycolate consumption. Total daily urinary oxalate excretion did not change. When indexed to creatinine there was a small but significant decrease in oxalate excretion. This is most likely due to hyperfiltration. These results indicate that as dietary protein intake increases, the catabolism of diet-derived amino acids is not associated with an increased endogenous oxalate synthesis in normal subjects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183980      PMCID: PMC2683385          DOI: 10.1007/s00240-009-0170-z

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  30 in total

1.  Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism.

Authors:  N A Breslau; L Brinkley; K D Hill; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

2.  Effect of animal and vegetable protein intake on oxalate excretion in idiopathic calcium stone disease.

Authors:  M Marangella; O Bianco; C Martini; M Petrarulo; C Vitale; F Linari
Journal:  Br J Urol       Date:  1989-04

Review 3.  Genetic factors in calcium oxalate stone disease.

Authors:  H O Goodman; R P Holmes; D G Assimos
Journal:  J Urol       Date:  1995-02       Impact factor: 7.450

4.  Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up.

Authors:  Eric N Taylor; Meir J Stampfer; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

5.  Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis.

Authors:  S Giannini; M Nobile; L Sartori; L Dalle Carbonare; M Ciuffreda; P Corrò; A D'Angelo; L Calò; G Crepaldi
Journal:  Am J Clin Nutr       Date:  1999-02       Impact factor: 7.045

6.  Aspects on estimation of the risk of calcium oxalate crystallization in urine.

Authors:  H G Tiselius
Journal:  Urol Int       Date:  1991       Impact factor: 2.089

Review 7.  Glyoxylate synthesis, and its modulation and influence on oxalate synthesis.

Authors:  R P Holmes; D G Assimos
Journal:  J Urol       Date:  1998-11       Impact factor: 7.450

8.  Relationship of protein intake to urinary oxalate and glycolate excretion.

Authors:  R P Holmes; H O Goodman; L J Hart; D G Assimos
Journal:  Kidney Int       Date:  1993-08       Impact factor: 10.612

9.  Increase in urinary calcium and oxalate after fructose infusion.

Authors:  N U Nguyen; G Dumoulin; M T Henriet; J Regnard
Journal:  Horm Metab Res       Date:  1995-03       Impact factor: 2.936

10.  Separation of enol and keto tautomers of aromatic pyruvic acids by paper chromatography.

Authors:  K SCHWARZ
Journal:  Arch Biochem Biophys       Date:  1961-01       Impact factor: 4.013

View more
  18 in total

1.  Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.

Authors:  Ruth Belostotsky; James Jonathon Pitt; Yaacov Frishberg
Journal:  J Mol Med (Berl)       Date:  2012-06-24       Impact factor: 4.599

2.  Metabolism of primed, constant infusions of [1,2-¹³C₂] glycine and [1-¹³C₁] phenylalanine to urinary oxalate.

Authors:  John Knight; Dean G Assimos; Michael F Callahan; Ross P Holmes
Journal:  Metabolism       Date:  2010-10-30       Impact factor: 8.694

3.  Internet program for facilitating dietary modifications limiting kidney stone risk.

Authors:  Jessica N Lange; Linda Easter; Robert Amoroso; Debra Benfield; Patrick W Mufarri; John Knight; Ross P Holmes; Dean G Assimos
Journal:  Can J Urol       Date:  2013-10       Impact factor: 1.344

4.  Whey protein and albumin effects upon urinary risk factors for stone formation.

Authors:  Camila Mithie Hattori; Hans-Göran Tiselius; Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2017-03-22       Impact factor: 3.436

5.  Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria.

Authors:  Juquan Jiang; Lynnette C Johnson; John Knight; Michael F Callahan; Travis J Riedel; Ross P Holmes; W Todd Lowther
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-29       Impact factor: 4.052

6.  Response to dietary oxalate after bariatric surgery.

Authors:  Leila Froeder; Carlos Haruo Arasaki; Carlos Alberto Malheiros; Alessandra Calábria Baxmann; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

7.  Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria.

Authors:  Candice B Summitt; Lynnette C Johnson; Thomas J Jönsson; Derek Parsonage; Ross P Holmes; W Todd Lowther
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

8.  Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones.

Authors:  Pietro Manuel Ferraro; Ernest I Mandel; Gary C Curhan; Giovanni Gambaro; Eric N Taylor
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-21       Impact factor: 8.237

Review 9.  Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease.

Authors:  W G Robertson
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

10.  A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy.

Authors:  Lupeng Ye; Jonathan J Park; Lei Peng; Quanjun Yang; Ryan D Chow; Matthew B Dong; Stanley Z Lam; Jianjian Guo; Erting Tang; Yueqi Zhang; Guangchuan Wang; Xiaoyun Dai; Yaying Du; Hyunu R Kim; Hanbing Cao; Youssef Errami; Paul Clark; Alexey Bersenev; Ruth R Montgomery; Sidi Chen
Journal:  Cell Metab       Date:  2022-03-10       Impact factor: 31.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.